Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AUPH
AUPH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AUPH News
Aurinia Pharmaceuticals CEO Acquires Shares Worth $12.5 Million
Jun 07 2026
NASDAQ.COM
Aurinia CEO Kevin Tang Acquires 814,606 Shares
Jun 07 2026
Fool
Director Paul J. Fribourg Acquires 273,500 Shares of IFF
Jun 03 2026
NASDAQ.COM
Tang Capital Acquires Shares of Aurinia Pharmaceuticals
Jun 03 2026
seekingalpha
Aurinia Reports 23% Revenue Growth in Q1
May 07 2026
stocktwits
Aurinia Pharmaceuticals Reports Q1 Earnings Growth
May 07 2026
NASDAQ.COM
Aurinia Pharmaceuticals Q1 Earnings Exceed Expectations
May 07 2026
seekingalpha
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
Aurinia Acquires Kezar Life Sciences for $6.955 per Share
Mar 30 2026
seekingalpha
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences in $6.955 Per Share Deal
Mar 30 2026
NASDAQ.COM
AURINIA PHARMACEUTICALS TO PURCHASE KEZAR LIFE SCIENCES FOR $6.955 PER SHARE IN CASH, ALONG WITH A CONTINGENT VALUE RIGHT
Mar 30 2026
moomoo
Aurinia Appoints New CEO and CFO Amid Shareholder Concerns
Mar 23 2026
stocktwits
Aurinia Appoints New CEO to Enhance Shareholder Value
Mar 23 2026
Newsfilter
Aurinia Pharmaceuticals Appoints New CEO and Executives
Mar 23 2026
seekingalpha
Overview of 13D Filings
Mar 14 2026
Yahoo Finance
Aurinia and Vornado Executives Make Significant Stock Purchases
Mar 04 2026
NASDAQ.COM
Show More News
